Author:
Katanasaka Yasufumi,Ida Tomoko,Asai Tomohiro,Shimizu Kosuke,Koizumi Fumiaki,Maeda Noriyuki,Baba Kazuhiko,Oku Naoto
Reference28 articles.
1. Angiogenesis in life, disease and medicine;Carmeliet;Nature,2005
2. Tumour vascular targeting;Neri;Nat. Rev. Cancer,2005
3. The biology of VEGF and its receptors;Ferrara;Nat. Med.,2003
4. Angiogenesis as a strategic target for ovarian cancer therapy;Spannuth;Nat. Clin. Pract. Oncol.,2008
5. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types;Fong;Cancer Res.,1999
Cited by
39 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献